GREAT Symposium & Keynote Speakers

--------------------------------------------------------------------------------------------

OU College of Pharmacy 125th Anniversary Celebration with ZDoggMD

April 9, 2018, 12:00 - 1:00 pm, Nicholson Tower Auditorium (overflow seating in College of Pharmacy classroom 103 with live streaming)

ZDoggMD

Speaker: "ZDoggMD", AKA Zubin Damania, MD

 Dr. Damania is an internist and the founder of Turntable Health, an innovative healthcare startup that was part of an ambitious urban revitalization movement in Las Vegas. During a decade-long hospitalist career at Stanford, he experienced dysfunctional health care system firsthand. After feeling burned out and depressed, he created videos under the pseudonym ZDoggMD as an outlet to find his voice. This launched a grassroots movement — a quarter billion views and a passionate tribe dedicated to improving health care for everyone.

This event is sponsored and hosted by the OU College of Pharmacy. The GREAT Committee is also advertising this event on campus and holding time during GREAT week for Graduate College students and postdocs to attend.

--------------------------------------------------------------------------------------------

GREAT Symposium Workshop: Academic Integrity

April 9, 2018, 4:00 pm -5:00 pm, Bird Library Auditorium (LIB 299)

2018GREAT_Clark

Speaker:  Breea Clark, J.D.
Associate Director of Academic Integrity Programs, OU Norman

Breea Clark was involved in the creation of The University of Oklahoma Office of Academic Integrity Programs after completing her law degree from the OU College of Law in 2008. Breea has now served as Associate Director of Academic Integrity Programs for over ten years. In addition to her work on the OU campus, she is committed to serving her community in Norman, Oklahoma. She has served as president of the Norman PTA Council and currently represents Norman’s Ward 6 distract as councilwoman. She is passionate about serving the community and promoting integrity both within education, local government, and throughout the community. 

This is a co-sponsored event between the Student Government Association (SGA) and the Graduate Student Association (GSA) at the OUHSC.

--------------------------------------------------------------------------------------------

GREAT Symposium Workshop: Cultural Awareness

April 10, 2018, 12:15 pm - 1:15 pm, Bird Library Auditorium (LIB 299)

2018GREAT_Verschelden

Speaker: Cia Verschelden, MSW, EdD

Executive Director, Office of Institutional Assessment

University of Central Oklahoma

Dr. Cia Verschelden currently serves as the Executive Director of the Office of Institutional Assessment at the University of Central Oklahoma. In this role, Dr. Verschelden employs equity-enhancing strategies in her classes and works with student affairs professionals on university-wide projects focused on creating identity-safe environments for all students. Her current research studies effectiveness of Life Reports for helping students learn about themselves and connect with others. Dr. Verschelden was faculty for twenty years at Kansas State University. While at K-state, she served in various roles ranging from faculty, Director of the Women's Studies Program to Director of the Office of Assessment. She has also has served as Vice President of Academic Affairs at Highland Community College in Kansas and worked in assessment of studentlearning at the Higher Learning Commission in Chicago. Dr. Verschelden’s life long work is studying and writing about how poverty, racism, and other “differentisms” rob students of mental bandwidth and how we can help them recover. Her book, Bandwidth Recovery: Helping Students Reclaim Cognitive Resources Lost to Poverty, Racism, and Social Marginalization, was published in 2017. Dr. Verschelden has a B.S. in psychology from Kansas State University, an M.S.W. in Social Policy from The University of Connecticut, and an Ed.D. in Interpersonal Development from Harvard University.

--------------------------------------------------------------------------------------------

GREAT Symposium Workshop: Career Development

April 11, 2018, 12:15 pm - 1:15 pm, Bird Library Auditorium (LIB 299)

2018GREAT_Droegemeier

Speaker: Kelvin K. Droegemeier, PhD

Vice President for Research, Regent's Professor of Meteorology

The University of Oklahoma

Dr. Kelvin K. Droegemeier is Vice President for Research, Regents’ Professor of Meteorology, Weather news Chair Emeritus, and Teigen Presidential Professor at the University of Oklahoma. He currently serves as Cabinet Secretary of Science and Technology for Governor Fallin. He earned a B.S. with Special Distinction in Meteorology in 1980 from the University of Oklahoma, and M.S. and Ph.D. degrees in atmospheric science in 1982 and 1985, respectively, from the University of Illinois at Urbana-Champaign. He joined the University of Oklahoma in September, 1985 as an Assistant Professor of Meteorology, and was cofounder in 1989 of the National Science Foundation (NSF) Science and Technology Center (STC) for Analysis and Prediction of Storms (CAPS), serving for five years as its deputy director. He then directed CAPS from 1994 until 2006, and today CAPS is recognized around the world as the pioneer of storm-scale numerical weather prediction. In 2003, Dr. Droegemeier co-founded the NSF Engineering Research Center for Collaborative Adaptive Sensing of the Atmosphere (CASA) and served for several years as its deputy director. From 1999-2001, he wrote a daily weather science column for the Daily Oklahoman newspaper, which is Oklahoma's largest.

--------------------------------------------------------------------------------------------

GREAT Symposium: Career Round Table Discussion

April 12, 2018, 9:00 am - 10:30 am, Bird Library Auditorium (LIB 299)

Confirmed Panelists:

  • 2018GREAT_Shimasaki
  • Craig Shimasaki, PhD - President & CEO, Moleculera Labs; CEO BioSource Consulting Group; Entrepreneur-in-Residence, OU School of Entrepreneurship. Oklahoma City, OK
  • 2018GREAT_Vedham
  • Vidya Vedham, PhD - Program Officer, Center for Global Health, National Cancer Institute, National Institutes of Health. Washington, DC
  • 2018GREAT_Williams
  • Rhonda Clark, PhD - Senior Criminalist, Oklahoma State Bureau of Investigation; Adjunct Faculty, University of Central Oklahoma. Oklahoma City, OK
  • 2018GREAT_Hale
  • Jessica Hale, MS - Data Scientist, Oklahoma Tobacco Research Center. Oklahoma City, OK
  • 2018GREAT_Crosswhite
  •  

 

  • Patrick Crosswhite, PhD - Assistant Professor, Department of Human Physiology, Gonzaga University

 --------------------------------------------------------------------------------------------

GREAT Symposium Keynote Speaker

April 12, 2018, 1:30pm - 2:15pm, Samis Center Auditorium

Keynote Speaker: 

2018GREAT_Rollins

Dr. Scott Rollins

 CEO and Chairman, Tetherex Pharmaceuticals,

Past President and CEO at Selexys Pharmaceuticals,
Past Co-founder and Senior Vice President of Alexion Pharmaceuticals, In
c.

Dr. Rollins is Chairman and CEO of Tetherex Pharmaceuticals. He was previously President and CEO of Selexys Pharmaceuticals from 2008 to 2016 and was instrumental in the acquisition of Selexys by Novartis in 2016 for $665M. Selexys developed a monoclonal antibody targeting P-Selectin that will be the first approved drug for sickle cell disease in 25 years. Dr. Rollins brings over 30 years of experience in the discovery, development and commercialization of antibody-based drugs. He was a co-founder of Alexion in 1992 and served as Head of Drug Development at Alexion Pharmaceuticals. Alexion raised over $800M in the private and public markets between 1992 and 2007 and currently has a market cap of over $30B. He was responsible for the discovery, preclinical and clinical development of eculizumab (Soliris), a humanized monoclonal antibody that was approved by the FDA and the EMEA in 2007 for the rare blood disease PNH and currently has yearly sales of $3.5B. Dr. Rollins has extensive experience with the FDA and led the drug development team that generated the regulatory approval filings (BLA, MAA) for Soliris. In addition, Dr. Rollins has managed more that 24 clinical trials and generated and filed 11 IND's. Dr. Rollins received a Ph.D. in Immunology from the University of Oklahoma in 1990, followed by postdoctoral work at Yale University. In 1992 he co-founded Alexion Pharmaceuticals. His work has led to more than 50 publications, 20 patents and $20 million in SBIR grant funding.